6 completed. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 6 |
Follow fosamprenavir: new trials by email Literature Review of fosamprenavir trials Research Report on fosamprenavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen Dolutegravir, PI, 2 NRTI - HIV-1 | Phase 4 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 44 | 2015-06-01 | 2017-06-14 |
| MARCH Renal Substudy arm 1 nucleotide analogue reverse transcriptase inhibitors and boosted protease inhibitors, Arm 2 boosted protease inhibitors and maraviroc, Arm 3 nucleotide analogue reverse transcriptase inhibitors and maraviroc - Proteinuria, HIV | Phase 4 | Completed | Kirby Institute | 76 | 2012-06-01 | 2016-01-20 |
| HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir Fosamprenavir - Chronic HIV Infection, HCV Coinfection | Phase 4 | Completed | Fundacion SEIMC-GESIDA | 42 | 2011-03-01 | 2014-05-30 |
| Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects Lovaza, fosamprenavir/ritonavir - Hypertriglyceridemia, HIV Infection | Phase 4 | Completed | Felizarta, Franco, M.D. | 36 | 2009-09-01 | 2012-04-18 |
| "The Once A Day Protease Inhibitor Regimens" ritonavir-boosted atazanavir, ritonavir-boosted fosamprenavir - HIV Infections | Phase 4 | Completed | The University of Texas Health Science Center, Houston | 76 | 2004-05-01 | 2014-01-15 |
| Fosamprenavir Expanded Access fosamprenavir, TelzirĀ® - Infection, Human Immunodeficiency Virus | Phase 4 | Completed | ViiV Healthcare | 85 | 2003-07-01 | 2016-09-12 |
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · Coinfection (1) · Hypertriglyceridemia (1) · Infections (1) · Proteinuria (1)
Felizarta, Franco, M.D. (1) · Fundacion SEIMC-GESIDA (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Kirby Institute (1) · The University of Texas Health Science Center, Houston (1) · ViiV Healthcare (1)
Spain (2) · United States (2) · Argentina (1) · Australia (1) · Canada (1) · Germany (1) · Japan (1) · Mexico (1) · Switzerland (1) · Thailand (1) · United Kingdom (1)
Franco Felizarta, MD (1) · Juan Gonzalez, MD (1) · Mark Kelly, MD (1) · Roberto C Arduino, MD (1) · Waldo Belloso, MD (1)